SCHEMBL14374231

SCHEMBL14374231

CCc1nc(=O)n(C)c2c1ccc1cnccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.39
▸ ROCK2 O75116 2/20 0.39
▸ ROCK1 Q13464 2/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ AURKA O14965 1/20 0.39
▸ DAPK3 O43293 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ PRKACA P17612 1/20 0.39
▸ RPS6KB1 P23443 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ MARK3 P27448 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14374646 0.89 HTR2C (0.39) MAPK1ROCK2ROCK1HTR2AHTR2C
SCHEMBL14347542 0.81 ROCK2 (0.36) MAPK1ROCK2ROCK1HTR2AHTR2C
SCHEMBL14374782 0.74 PDE10A (0.41) HTR2AHTR2CHTR2BMAT2AMAPT
SCHEMBL14374643 0.74 CCR1 (0.40) MAPK1HTR2AHTR2CHTR2BMAT2A
SCHEMBL14374820 0.70 AURKA (0.40) MAPK1ROCK2ROCK1HTR2AHTR2C
SCHEMBL14347562 0.69 HTR2A (0.36) HTR2AHTR2CHTR2BDYRK1AADORA3
SCHEMBL25703672 0.68 ALKBH5 (0.47) HTR2AHTR2CHTR2BMAPT
SCHEMBL12650509 0.65 PDE3B (0.41) MAPK1ROCK2ROCK1HTR2AHTR2C
SCHEMBL14374602 0.65 MAT2A (0.49) MAPK1MAT2AALDH1A1MAPT
Ammonia Solution, Strong SCHEMBL905803 0.64 HTR2A (0.66) ROCK2ROCK1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312211-B2 Pryanone compounds useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2007-12-25 — — US disclosed
Send feedback